Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
This study is currently recruiting participants.
Study NCT00600275   Information provided by Novartis
First Received: January 11, 2008   Last Updated: September 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors
Breast Cancer
Cowden Syndrome
Additional conditions recognized in this trial
Breast Neoplasms
Hamartoma Syndrome, Multiple
Syndrome
More general conditions related to this trial
Breast Diseases
Disease
Genetic Diseases, Inborn
Hamartoma
Neoplasms
Neoplasms by Site
Neoplasms, Multiple Primary
Neoplastic Syndromes, Hereditary
Pathologic Processes
Skin Diseases
Interventions listed in this trial
BGT226
Sponsors listed in this trial
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services